Quratis Co., Ltd.

Quratis Co., Ltd., a South Korean company, primarily focuses on the biopharmaceutical industry. Its core function is developing vaccines and therapies aimed at addressing infectious diseases, with significant research dedicated to combating tuberculosis. Noteworthy is the company's innovative approach to vaccine development, employing state-of-the-art biotechnological methods to enhance efficacy and safety. Serving a wide range of healthcare sectors, Quratis Co., Ltd. collaborates with medical institutions, research organizations, and public health bodies to support global health initiatives. Within the financial market, the company plays a critical role by contributing to the healthcare sector's growth and responding to emerging health challenges. Through its scientific advancements, Quratis Co., Ltd. not only aims to improve public health outcomes but also strengthens its position as a pivotal player in the biopharmaceutical landscape, aligning with South Korea's strategic emphasis on cutting-edge medical technology and innovation.